iNtRON Biotechnology Inc (048530.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · South Korea · ISIN KR7048530000
Price
2,555.00 KRW
Market cap
78.93 bn KRW
P/E (2025)
–
P/S (2025)
13.75
Dividend yield
0.00 %
Net margin
-156.06 %
Return on equity (ROE)
-12.82 %
Return on assets (ROA)
-12.05 %
iNtRON Biotechnology Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 6.42 bn KRW | 5.74 bn KRW |
| Gross profit | 3.74 bn KRW | 3.10 bn KRW |
| Operating income | -5.24 bn KRW | -7.90 bn KRW |
| EBIT | -2.98 bn KRW | -8.94 bn KRW |
| Net income | -2.59 bn KRW | -8.96 bn KRW |
| Diluted EPS – continuing operations | -81.03 KRW | -290.00 KRW |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About iNtRON Biotechnology Inc
iNtRON Biotechnology, Inc. engages in the development of novel biopharmaceutical drugs in South Korea. It develops bacteriophage and endolysin based drugs through itLysin and IMPA platform. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
More stocks
- Shinih Enterprise Co Ltd (9944.TW)
- Media Nusantara Citra Tbk PT (MNCN.JK)
- Wavice Inc. (289930.KQ)
- SurplusGLOBAL, Inc. (140070.KQ)
- Mercuries F&B Co., Ltd. (7705.TW)
- Mgame Corp (058630.KQ)
- Intech Biopharm Ltd (6461.TWO)
- H.H.Galaxy Co., Ltd. (2949.TWO)
- Cs Holdings (000590.KS)
- Taiwan Ostor (8080.TWO)
- TJ media Co. Ltd (032540.KQ)
- Everspring Industry Co Ltd (2390.TW)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.